Ask AI

ACTiconsult: Treatment Considerations for a Patient Case Example With Relapsed/Refractory Multiple Myeloma

Interact with our new AI patient case platform to talk about management of a patient with heavily pretreated relapsed/refractory multiple myeloma. This program will help you think through the use of CAR T-cell therapy and bispecific antibodies in R/R MM, including efficacy and safety insights and practical considerations for administration and adverse event monitoring.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education